Turnstone Biologics (TSBX) Earnings Date, Estimates & Call Transcripts $0.35 0.00 (-0.93%) Closing price 08/1/2025 03:47 PM EasternExtended Trading$0.35 +0.00 (+0.51%) As of 08/1/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Turnstone Biologics Earnings Summary Turnstone Biologics announced Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.51, which missed analysts' consensus estimates of -$0.26 by $0.25. With a trailing EPS of -$2.73, Turnstone Biologics' earnings are expected to grow next year, from ($3.32) to ($0.89) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 8) -$0.26 Actual EPS (May. 8) -$0.51 Missed By -$0.25 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)TSBX Upcoming EarningsTurnstone Biologics' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Turnstone Biologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turnstone Biologics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTSBX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Turnstone Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.26-$0.26-$0.26Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.14-$0.14-$0.14Q4 20251-$0.13-$0.13-$0.13 FY 2025 4 -$0.69 -$0.69 -$0.69 Q1 20261-$0.13-$0.13-$0.13Q2 20261-$0.13-$0.13-$0.13Q3 20261-$0.13-$0.13-$0.13Q4 20261-$0.13-$0.13-$0.13 Turnstone Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/8/2025Q1 2025-$0.26-$0.51 -$0.25-$0.51--3/28/2025Q4 2024-$0.69-$0.56+$0.13-$0.56--11/12/2024--$0.87-$0.74+$0.13-$0.74--8/14/2024--$0.84-$0.92 -$0.08-$0.92--5/13/2024Q1 2024-$0.78-$0.85 -$0.07-$0.85--3/21/2024Q4 2023-$0.86-$0.73+$0.13-$0.73--11/9/2023Q3 2023-$0.67-$1.00 -$0.33-$1.00--9/1/2023Q2 2023-$3.01-$7.56 -$4.55-$7.56-- Turnstone Biologics Earnings - Frequently Asked Questions When is Turnstone Biologics' earnings date? Turnstone Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on TSBX's earnings history. Did Turnstone Biologics beat their earnings estimates last quarter? In the previous quarter, Turnstone Biologics (NASDAQ:TSBX) missed the analysts' consensus estimate of ($0.26) by $0.25 with a reported earnings per share (EPS) of ($0.51). Learn more on analysts' earnings estimate vs. TSBX's actual earnings. How much revenue does Turnstone Biologics generate each year? Turnstone Biologics (NASDAQ:TSBX) has a recorded annual revenue of $19.31 million. How much profit does Turnstone Biologics generate each year? Turnstone Biologics (NASDAQ:TSBX) has a recorded net income of -$70.84 million. TSBX has generated -$2.73 earnings per share over the last four quarters. What is Turnstone Biologics' EPS forecast for next year? Turnstone Biologics' earnings are expected to grow from ($3.32) per share to ($0.89) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kezar Life Sciences Earnings Generation Bio Earnings Rein Therapeutics Earnings Iterum Therapeutics Earnings OnKure Therapeutics Earnings Enlivex Therapeutics Earnings Tempest Therapeutics Earnings Promis Neurosciences Earnings FibroGen Earnings MIRA Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:TSBX) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
